A Study to Evaluate the Changes in Visual Acuity in Patients With Wet Age Related Macular Degeneration Treated With Ranibizumab
Latest Information Update: 11 May 2016
Price :
$35 *
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- Acronyms TWIN
- 11 May 2016 New trial record